Department of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine, Nanning, 530023, People's Republic of China.
Department of Surgery, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine, No. 89-9 Dongge Road, Nanning, 530000, Guangxi, People's Republic of China.
Mol Biol Rep. 2024 May 10;51(1):638. doi: 10.1007/s11033-024-09554-x.
Treatment-resistant depression (TRD) is a condition in a subset of depressed patients characterized by resistance to antidepressant medications. The global prevalence of TRD has been steadily increasing, yet significant advancements in its diagnosis and treatment remain elusive despite extensive research efforts. The precise underlying pathogenic mechanisms are still not fully understood. Epigenetic mechanisms play a vital role in a wide range of diseases. In recent years, investigators have increasingly focused on the regulatory roles of miRNAs in the onset and progression of TRD. miRNAs are a class of noncoding RNA molecules that regulate the translation and degradation of their target mRNAs via interaction, making the exploration of their functions in TRD essential for elucidating their pathogenic mechanisms.
A systematic search was conducted in four databases, namely PubMed, Web of Science, Cochrane Library, and Embase, focusing on studies related to treatment-resistant depression and miRNAs. The search was performed using terms individually or in combination, such as "treatment-resistant depression," "medication-resistant depression," and "miRNAs." The selected articles were reviewed and collated, covering the time period from the inception of each database to the end of February 2024. We found that miRNAs play a crucial role in the pathophysiology of TRD through three main aspects: 1) involvement in miRNA-mediated inflammatory responses (including miR-155, miR-345-5p, miR-146a, and miR-146a-5p); 2) influence on 5-HT transport processes (including miR-674,miR-708, and miR-133a); and 3) regulation of synaptic plasticity (including has-miR-335-5p,has-miR- 1292-3p, let-7b, and let-7c). Investigating the differential expression and interactions of these miRNAs could contribute to a deeper understanding of the molecular mechanisms underlying TRD.
miRNAs might play a pivotal role in the pathogenesis of TRD. Gaining a deeper understanding of the roles and interrelations of miRNAs in TRD will contribute to elucidating disease pathogenesis and potentially provide avenues for the development of novel diagnostic and therapeutic strategies.
治疗抵抗性抑郁症(TRD)是一种抗抑郁药物治疗无效的抑郁症患者亚群的特征。尽管进行了广泛的研究,但 TRD 的全球患病率仍在稳步上升,但在其诊断和治疗方面仍未取得显著进展。确切的潜在发病机制仍不完全清楚。表观遗传机制在广泛的疾病中起着至关重要的作用。近年来,研究人员越来越关注 miRNA 在 TRD 的发病和进展中的调节作用。miRNA 是一类非编码 RNA 分子,通过相互作用调节其靶 mRNA 的翻译和降解,因此探索其在 TRD 中的功能对于阐明其发病机制至关重要。
在四个数据库(PubMed、Web of Science、Cochrane Library 和 Embase)中进行了系统搜索,重点是与治疗抵抗性抑郁症和 miRNA 相关的研究。使用单独或组合的术语(如“治疗抵抗性抑郁症”、“药物抵抗性抑郁症”和“miRNA”)进行搜索。选择的文章进行了审查和整理,涵盖了每个数据库成立到 2024 年 2 月底的时间段。我们发现,miRNA 通过三个主要方面在 TRD 的病理生理学中发挥关键作用:1)参与 miRNA 介导的炎症反应(包括 miR-155、miR-345-5p、miR-146a 和 miR-146a-5p);2)对 5-HT 转运过程的影响(包括 miR-674、miR-708 和 miR-133a);3)调节突触可塑性(包括 has-miR-335-5p、has-miR-1292-3p、let-7b 和 let-7c)。研究这些 miRNA 的差异表达和相互作用可能有助于更深入地了解 TRD 潜在的分子机制。
miRNA 可能在 TRD 的发病机制中起关键作用。深入了解 miRNA 在 TRD 中的作用和相互关系将有助于阐明疾病的发病机制,并可能为新的诊断和治疗策略的发展提供途径。